Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects
Clinical trial NCT01856426 · COMPLETED
Trial details
- NCT number
- NCT01856426
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.